SFRP2 and myocardial infarction: Knockdown of Safe mitigates both TGF-β and MI-induced cardiac fibrosis, and improves heart function by inhibiting Sfrp2-mediated activation of fibroblast proliferation, fibroblast-myofibroblast transition, and deposition of ECM.